Document approval, checklist, certification, quality control concept, Businesswomen use tallets tick correct mark approval document, Quality management assurance.
Adobe Stock
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Embattled gasfield developer Strike Energy (ASX:STX) has won a key approval from the EPA to continue developing the West Erregulla asset overlying the onshore Perth Basin.

At the same time, Australia Gas Infrastructure Group (AGIG) have won approval to build out a pipeline on-site to be used by Strike in the near future, all things in order.

The EPA approval was handed down to Strike by way of a Ministerial Statement after a three year period satisfying environmental study requirements.

However, Strike isn’t out of the woods yet when it comes to community consultation – under the EPBC Act, there must be another 10 day review period. Strike anticipates approval to come this quarter regardless.

The EPA approval relates to the EP469 licence JV which sees Strike operate the asset but otherwise share it 50/50 with Warrego Energy.

The news could be well received by long term shareholders. Strike has been suffering YTD with 1Y returns down -47%.

The company hit a duster earlier this year downhole what was expected to be a more promising well. Strike also locked down terms for a $153M development funding package back in June.

That duster really did knock Strike off a good run (though it still has a market cap over $600M.) At one point following the release of that news in February, nearly a third of Strike Energy’s entire value was wiped off in one trading day.

STX last traded at 22cps.

STX by the numbers
More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next